课题基金 / 基金详情

Development of Regenerative Medicine Using Reversibly Proliferating Human Bone Marrow Mesenchymal Stem Cells

Development of Regenerative Medicine Using Reversibly Proliferating Human Bone Marrow Mesenchymal Stem Cells
利用可逆增殖的人骨髓间充质干细胞开发再生医学
批准号:
15390378
负责人:
TANAKA Noriaki
金额:
$9.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

TANAKA Noriaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Researchers have paid close attention to human bone marrow mesenchymal stem cells(HBMSCs), because HBMSCs have potentials to differentiate to various types of tissue functional cells. Using a retroviral vector SSR#197, encoding LoxP-flanked human telomerase reverse transcriptase and green fluorescence protein cDNAs, we have successfully established an immortalized HMBMSC line YKNT-12. YKNT-12 cells were able to proliferate unlimitedly, on the other hand, normal HBMSCs stopped their proliferation at population doubling 30, indicating a limited life. YKNT-12 cells efficiently differentiated to osteocytes, adipocytes, and chondrocytes by adding specific growth factors in the culture medium, respectively. To differentiate YKNK-12 cells to other-typed cells, genetic manipulation is an important. Thus, we have investigated the usefulness of a lentiviral vector for such gene manipulation in mouse embryonic stem cells(ECs). After lentiviral transduction, mouse ECs still obtained multi-differentiation potentials. Therefore, a lentiviral vector will be one of the useful tools in gene manipulation in YKNK-12 cells and human ECs.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
間葉系幹細胞による骨や脂肪に再生
间充质干细胞再生为骨骼和脂肪
DOI: --
发表时间: 2004
期刊: 化学工業 55(7)
影响因子: --
作者: [Takada, M, Tada M, Tamoto E, Kawakami A, Murakawa K, Shindoh G, Teramoto K-I, Matsunaga A, Komuro K, Kanai M, Fujiwara Y, Shirata K, Nishimura N, Miyamoto M, Okushiba S-I, Kondo S, Hamada J-I, Katoh H, Yoshiki T, Moriuchi T, 小林直哉]
通讯作者: 小林直哉
Regeneration of bone and fat using mesenchymal stem cells.
使用间充质干细胞再生骨骼和脂肪。
DOI: --
发表时间: 2004
期刊: Chemical Industry 55(7)
影响因子: --
作者: [Naoya Kobayashi]
通讯作者: Naoya Kobayashi
小林直哉 他: "Cre/loxPシステム"Surgery Frontier. 10(3). 62-65 (2003)
Naoya Kobayashi 等人:“Cre/loxP 系统”Surgery Frontier 10(3) (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
総合ビタミン製剤の連続投与が高度腎機能障害患者に及ぼす影響の解明
  • 批准号:
    19H00350
  • 项目类别:
    Grant-in-Aid for Encouragement of Scientists
  • 资助金额:
    $0.35万
  • 财政年份:
    2019
  • 负责人:
    TANAKA Noriaki
  • 依托单位:
Contribution of chemokines and growth factors for the cervical lymph node metastasis in oral squamous cell carcinoma
  • 批准号:
    24792206
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.75万
  • 财政年份:
    2012
  • 负责人:
    TANAKA Noriaki
  • 依托单位:
The relationship of MMPs and growth factors in the invasion mechanism of adenoid cystic carcinoma
  • 批准号:
    20791561
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.66万
  • 财政年份:
    2008
  • 负责人:
    TANAKA Noriaki
  • 依托单位:
Hepatic differentiation of human embryonic stem cells and its application to the development of a bioartificial liver system
  • 批准号:
    19390334
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $12.15万
  • 财政年份:
    2007
  • 负责人:
    TANAKA Noriaki
  • 依托单位:
国内基金
海外基金
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
  • 批准号:
    82370979
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张善勇
  • 依托单位:
ROS/TXNIP/NLRP3信号轴调控TCP磨损颗粒所致假体周围骨细胞(osteocyte)焦亡研究
  • 批准号:
    LY21H060001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    张云
  • 依托单位:
PERK-eIF2α介导的内质网应激-自噬通路参与调控正畸牙移动压力区骨细胞(osteocyte)损伤研究
  • 批准号:
    81700936
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    严明
  • 依托单位: